Central Trust Company’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Central Trust Company's RGEN Position: Q1 2026 in Review
Central Trust Company held its Repligen (RGEN) position steady in Q1 2026 at 30 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.
Central Trust Company first reported a position in RGEN in Q4 2017 and has held it in 24 quarters since. The position peaked at $287K in Q4 2020. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Central Trust Company held 30 shares of Repligen worth $3.54K as of Q1 2026.
- Central Trust Company left its Repligen share count unchanged in Q1 2026.
- Repligen made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1306 holding.
- Central Trust Company first reported a position in Repligen in Q4 2017 and has held it in 24 quarters since.
- Central Trust Company's Repligen position peaked at $287K in Q4 2020.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.